Ultrasonic Formation of Fe3O4-Reduced Graphene Oxide-Salicylic Acid Nanoparticles with Switchable Antioxidant Function.

We demonstrate a single-step ultrasonic in situ complexation of salicylic acid during the growth of Fe3O4-reduced graphene oxide nanoparticles (∼10 nm) to improve the antioxidant and antiproliferative effects of pristine drug molecules. These nanoparticles have a precisely defined electronic molecular structure with salicylic acid ligands specifically complexed to Fe(III)/Fe(II) sites, four orders of magnitude larger electric surface potential, and enzymatic activity modulated by ascorbic acid molecules. The diminishing efficiency of hydroxyl radicals by Fe3O4-rGO-SA nanoparticles is tenfold higher than that by pristine salicylic acid in the electro-Fenton process. The H+ production of these nanoparticles can be switched by the interaction with ascorbic acid ligands and cause the redox deactivation of iron or enhanced antioxidation, where rGO plays an important role in enhanced charge transfer catalysis. Fe3O4-rGO-SA nanoparticles are nontoxic to erythrocytes, i.e., human peripheral blood mononuclear cells, but surpassingly inhibit the growth of three cancer cell lines, HeLa, HepG2, and HT29, with respect to pristine salicylic acid molecules.

Sonochemical Formation of Copper/Iron-Modified Graphene Oxide Nanocomposites for Ketorolac Delivery.

A feasible sonochemical approach is described for the preparation of copper/iron-modified graphene oxide nanocomposites through ultrasonication (20 kHz, 18 W cm-2 ) of an aqueous solution containing copper and iron ion precursors. Unique copper-, copper/iron- and iron-modified graphene oxide nanocomposites have a submicron size that is smaller than that of pristine GO and a higher surface area enriched with Cu2 O, CuO, and Fe2 O3 of multiform phases (α-, ß-, ϵ-, or γ), FeO(OH), and sulfur- or carbon-containing compounds. These nanocomposites are sonochemically intercalated with the nonsteroidal anti-inflammatory drug ketorolac, which results in the formation of nanoscale carriers. Ketorolac monotonically disintegrates from these nanoscale carriers in aqueous solution upon adjustment of the pH from 1 to 8. The disintegration of ketorolac proceeds at a slower rate from the copper/iron-modified graphene oxide at increased pH, but at a faster rate from the iron-modified graphene oxide under acidic conditions.

Sonochemically Assembled Photoluminescent Copper-Modified Graphene Oxide Microspheres.

A new accessible sonochemical assembly method is developed for the preparation of photoluminescent oil-filled silica@CuS/Cu2O/CuO-graphene oxide (GO) microspheres that emit light of green, yellow, and red colors. This method is based on the ultrasonic emulsification of a biphasic mixture consisting of CuS/Cu2O/CuO-graphene oxide (GO) nanocomposites with poly(vinyl alcohol) (PVA) (aqueous phase) and tetraethyl orthosilicate with sunflower oil (organic phase). CuS/Cu2O/CuO-GO nanocomposites are composed of sonochemically formed three phases of copper: covellite CuS (p-type semiconductor), cuprite Cu2O (Bloch p-type semiconductor), and CuO (charge-transfer insulator). The photoluminescence properties of microspheres result from H-bridging between PVA and CuS/Cu2O/CuO-GO nanostructures, light absorption ability of Cu2O, and charge-transfer insulation by CuO. Substitution of PVA by S-containing methylene blue quenches fluorescence by enhanced dye adsorption on CuS/Cu2O/CuO-GO because of CuS and induced charge transfer. Non-S-containing malachite green is in a nonionized form and tends to be in the oil phase, prohibiting the charge transfer on CuS/Cu2O/CuO-GO.